EMFAT
Emerald Mutual Fund Advisers Trust Portfolio holdings
AUM
$1.64B
This Quarter Return
+21.67%
1 Year Return
+51.67%
3 Year Return
+272.14%
5 Year Return
+503.14%
10 Year Return
+2,013.48%
AUM
$1.89B
AUM Growth
+$1.89B
(+14%)
Cap. Flow
-$14.2M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
258
New
22
Increased
81
Reduced
65
Closed
18
Top Buys
| 1 |
Q2 Holdings
QTWO
|
$13.6M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$9.09M |
| 3 |
Onto Innovation
ONTO
|
$8.92M |
| 4 |
Immunovant
IMVT
|
$8.61M |
| 5 |
Light & Wonder
LNW
|
$8.55M |
Top Sells
| 1 |
Simply Good Foods
SMPL
|
$19M |
| 2 |
EVRI
Everi Holdings
EVRI
|
$12.3M |
| 3 |
ICU Medical
ICUI
|
$11.7M |
| 4 |
Lantheus
LNTH
|
$11.2M |
| 5 |
MODN
MODEL N, INC.
MODN
|
$10.9M |
Sector Composition
| 1 | Healthcare | 27.44% |
| 2 | Technology | 21.28% |
| 3 | Industrials | 19.09% |
| 4 | Financials | 11.71% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Palomar
PLMR
$3.29B
| $20.8M | 1.1% | 375,266 +320 | +0.1% | +$17.8K |
|
|
CBAY
27
DELISTED
Cymabay Therapeutics
CBAY
| $20.7M | 1.1% | 878,275 +68,537 | +8% | +$1.62M |
|
28
BridgeBio Pharma
BBIO
$9.89B
| $20.2M | 1.07% | 500,254 | – | – |
|
29
LivaNova
LIVN
$3.08B
| $20.2M | 1.07% | 390,204 -112,925 | -22% | -$5.84M |
|
30
Rambus
RMBS
$7.94B
| $20.2M | 1.07% | 295,566 | – | – |
|
|
ITCI
31
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $20.1M | 1.06% | 280,589 -30,849 | -10% | -$2.21M |
|
32
PDF Solutions
PDFS
$808M
| $19.8M | 1.05% | 616,031 +162,191 | +36% | +$5.21M |
|
33
FormFactor
FORM
$2.25B
| $19.4M | 1.03% | 464,841 +69,401 | +18% | +$2.89M |
|
|
34
Onto Innovation
ONTO
$5.19B
| $19.3M | 1.02% | 126,328 +58,348 | +86% | +$8.92M |
|
35
Credo Technology Group
CRDO
$21.3B
| $19M | 1.01% | 977,828 +108,562 | +12% | +$2.11M |
|
36
Montrose Environmental
MEG
$1.1B
| $18.8M | 0.99% | 583,957 -51,738 | -8% | -$1.66M |
|
37
indie Semiconductor
INDI
$899M
| $18.7M | 0.99% | 2,307,275 +85,449 | +4% | +$693K |
|
38
Privia Health
PRVA
$2.83B
| $18.7M | 0.99% | 812,355 +70,224 | +9% | +$1.62M |
|
39
Ultragenyx Pharmaceutical
RARE
$2.89B
| $18.4M | 0.98% | 385,340 -1,983 | -0.5% | -$94.8K |
|
40
Herc Holdings
HRI
$4.35B
| $17.9M | 0.95% | 120,326 -6,285 | -5% | -$936K |
|
|
BWIN
41
Baldwin Insurance Group
BWIN
$2.26B
| $17.5M | 0.93% | 730,484 -29,033 | -4% | -$697K |
|
42
Collegium Pharmaceutical
COLL
$1.22B
| $17M | 0.9% | 551,794 -7,686 | -1% | -$237K |
|
43
First Advantage
FA
$2.85B
| $16.9M | 0.9% | 1,021,242 +259,474 | +34% | +$4.3M |
|
44
Jack in the Box
JACK
$364M
| $16.9M | 0.89% | 206,561 +3,958 | +2% | +$323K |
|
45
Rapid7
RPD
$1.34B
| $16.5M | 0.88% | 289,627 | – | – |
|
46
Houlihan Lokey
HLI
$14B
| $16.4M | 0.87% | 136,800 | – | – |
|
47
Axos Financial
AX
$5.15B
| $16.3M | 0.87% | 299,285 +136,981 | +84% | +$7.48M |
|
48
Cogent Communications
CCOI
$1.88B
| $16.3M | 0.86% | 214,726 | – | – |
|
|
49
Simply Good Foods
SMPL
$2.88B
| $16.3M | 0.86% | 410,971 -478,869 | -54% | -$19M |
|
50
Savers
SVV
$1.88B
| $16.2M | 0.86% | 930,155 +239,791 | +35% | +$4.17M |
|